(Q40940403)

English

The novel Trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness

scientific article published on June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

The novel Trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

based on heuristic

inferred from title

pancreatic carcinoma

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

author name string

Miknyoczki SJ

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Dionne CA

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Klein-Szanto AJ

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Ruggeri BA

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

880

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

252-262

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1999.TB09530.X

21 January 2018

Identifiers

10.1111/J.1749-6632.1999.TB09530.X

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40940403&oldid=1910929786"